Author: Dorron Blumberg

Baptist Health South Florida is one of the 2019 FORTUNE 100 Best Companies to Work For, according to global research and consulting firm Great Place to Work and Fortune. This is the 19th time Baptist Health has been recognized on the list. 

 

Baptist Health ranked #40 on the list, on which is based on survey feedback representing more than 4.3 million employees, with respondents rating their workplace culture on 60-plus elements of the workplace. These include trust in managers, compensation, fairness, camaraderie and workplace traits linked to innovation. The ranking accounted for the experiences of all employees. Once again, Baptist Health ranked #1 in diversity on the list.

 

Cheryl Van Hare, physician assistant, joins the Alzheimer’s Association® as the 2019 Walk to End Alzheimer’s event chair in Boca Raton. She is joined by co-chair Doreen Yaffa, founder of Yaffa and Associates – Marital and Family Law Attorney’s.

 

“I’ve been involved with the Boca Raton Walk to End Alzheimer’s for six years," Van Hare said. "Sadly, my mom passed away in 2012 after years of decline due to dementia— I was very involved with her care. I heard about the planning committee in 2014 to start a walk in Boca Raton— I was all in, and there’s been no looking back. I have been involved in various roles each year, and am excited to chair the event this year.”

 

T2 Protect AD Study at University of Miami Measures Potential Improvement in People with Mild-to-Moderate AD through Use of Troriluzole

 

Neurologists and researchers with the University of Miami Miller School of Medicine and UHealth—the University of Miami Health System have begun screening study participants for a new, national Alzheimer’s disease (AD) clinical study to evaluate the potential benefits of an investigational medicine for people with mild-to-moderate AD.

 

The Phase 2 study, called T2 Protect AD, is evaluating the investigational drug troriluzole (BHV-4157), which may have the potential to protect against, slow down, and eventually improve memory and thinking problems that increase as Alzheimer’s disease progresses. Troriluzole is a drug that modulates glutamate, protecting against neuron loss. Glutamate problems in the brain can lead to brain cell dysfunction and disease, including Alzheimer’s disease.